| ATPC 0.1157 65.29% | MTEN 0.0323 -8.50% | OCG 0.0098 -16.95% | SOXS 2.065 -9.43% | AUID 2.295 131.23% | CJMB 5.0131 347.60% | IVP 0.0477 -41.83% | ZSL 2.9499 4.61% | SLV 82.9899 -1.86% | NVDA 187.4686 2.36% | SPHL 16.5703 636.46% | INTC 49.117 0.81% | APLT 0.1014 1.50% | BNKK 4.34 56.12% | DVLT 0.7402 3.06% | SOXL 60.9973 10.14% | TQQQ 55.57 3.23% | ASST 0.9927 -3.62% | BYND 1.02 6.04% | TZA 5.905 -4.14% | GRAB 4.41 -4.75% | TSLL 18.3793 1.71% | EEM 58.31 0.97% | ONDS 13.055 -3.72% | BBAI 6.375 1.84% | TSLS 5.145 -0.87% | SPY 694.78 0.64% | IBRX 3.6479 20.79% | MSTX 4.96 -4.62% | NOK 6.725 5.74% | DUST 5.775 -0.43% | AMD 236.295 5.68% | SIDU 3.595 -4.13% | RZLV 4.69 15.52% | BITO 13.39 -1.25% | IBIT 54.725 -1.29% | JTAI 0.4753 4.55% | AAL 15.765 4.13% | NVD 7.065 -4.66% | VALE 14.755 0.99% | QQQ 626.2588 1.08% | PLUG 2.34 -0.43% | SQQQ 64.7999 -3.20% | TSM 349.625 6.88% | XLF 54.585 0.80% | TSLA 443.0155 0.87% | CRWV 98.9301 10.17% | SEGG 1.0905 17.68% | CAN 0.8098 -7.46% | PTHL 0.5285 20.17%

Understanding Market Valuations: A Comparative Analysis

Chicago Atlantic BDC, Inc. (NASDAQ:LIEN) is showing promising growth potential. LIEN is trading at $10.10, but its discounted cash flow (DCF) valuation is $14.35. This results in a price percentage difference of 42.03%, suggesting a positive outlook and potential for price appreciation. LIEN's strong position among its peers highlights its growth prospects.

Cinemark Holdings, Inc. (NYSE:CNK) is another peer, trading at $30.64 with a DCF of $18.05. This results in a price percentage difference of -41.08%, indicating a less favorable outlook compared to its current market price. Despite being a well-known name in the entertainment industry, CNK faces challenges in aligning its market price with its valuation.

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) trades at $0.389 with a DCF of $0.3556, showing a price percentage difference of -8.57%. This smaller discrepancy suggests a closer alignment between its market price and valuation, though it still indicates a slightly negative outlook. VRPX's focus on pharmaceutical developments may influence its market performance.

Regis Corporation (NYSE:RGS) is trading at $22.65, but its DCF is only $1.95, resulting in a significant price percentage difference of -91.37%. This large gap suggests a highly pessimistic view from analysts, similar to RGC. RGS's market challenges are evident in its substantial discrepancy between market price and valuation.

Published on: July 5, 2025